BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

501 related articles for article (PubMed ID: 7967662)

  • 1. Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and nonsurveyed patients.
    Peters JH; Clark GW; Ireland AP; Chandrasoma P; Smyrk TC; DeMeester TR
    J Thorac Cardiovasc Surg; 1994 Nov; 108(5):813-21; discussion 821-2. PubMed ID: 7967662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome of esophageal adenocarcinoma detected during endoscopic biopsy surveillance for Barrett's esophagus.
    Incarbone R; Bonavina L; Saino G; Bona D; Peracchia A
    Surg Endosc; 2002 Feb; 16(2):263-6. PubMed ID: 11967675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Impact of endoscopic surveillance of Barrett's esophagus on survival of patients with esophageal adenocarcinoma].
    Incarbone R; Bonavina L; Bassi F; Peracchia A
    Chir Ital; 2002; 54(5):591-6. PubMed ID: 12469454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is Barrett's metaplasia the source of adenocarcinomas of the cardia?
    Clark GW; Smyrk TC; Burdiles P; Hoeft SF; Peters JH; Kiyabu M; Hinder RA; Bremner CG; DeMeester TR
    Arch Surg; 1994 Jun; 129(6):609-14. PubMed ID: 8204035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The rationale for esophagectomy as the optimal therapy for Barrett's esophagus with high-grade dysplasia.
    Edwards MJ; Gable DR; Lentsch AB; Richardson JD
    Ann Surg; 1996 May; 223(5):585-9; discussion 589-91. PubMed ID: 8651749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Jumbo biopsy forceps protocol still misses unsuspected cancer in Barrett's esophagus with high-grade dysplasia.
    Falk GW; Rice TW; Goldblum JR; Richter JE
    Gastrointest Endosc; 1999 Feb; 49(2):170-6. PubMed ID: 9925694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surveillance in Barrett's esophagus: an audit of practice.
    Ajumobi A; Bahjri K; Jackson C; Griffin R
    Dig Dis Sci; 2010 Jun; 55(6):1615-21. PubMed ID: 19669878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term survival after esophagectomy for Barrett's adenocarcinoma in endoscopically surveyed and nonsurveyed patients.
    Ferguson MK; Durkin A
    J Gastrointest Surg; 2002; 6(1):29-35; discussion 36. PubMed ID: 11986015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Barrett's esophagus: a retrospective analysis of 13 years surveillance.
    Switzer-Taylor V; Schlup M; Lübcke R; Livingstone V; Schultz M
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1362-7. PubMed ID: 18205769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The development of dysplasia and adenocarcinoma during endoscopic surveillance of Barrett's esophagus.
    Katz D; Rothstein R; Schned A; Dunn J; Seaver K; Antonioli D
    Am J Gastroenterol; 1998 Apr; 93(4):536-41. PubMed ID: 9576444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Barrett's esophagus, high-grade dysplasia, and early adenocarcinoma: a pathological study.
    Cameron AJ; Carpenter HA
    Am J Gastroenterol; 1997 Apr; 92(4):586-91. PubMed ID: 9128304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EUS followed by EMR for staging of high-grade dysplasia and early cancer in Barrett's esophagus.
    Larghi A; Lightdale CJ; Memeo L; Bhagat G; Okpara N; Rotterdam H
    Gastrointest Endosc; 2005 Jul; 62(1):16-23. PubMed ID: 15990814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of Barrett's esophagus with high-grade dysplasia.
    McAllaster JD; Buckles D; Al-Kasspooles M
    Expert Rev Anticancer Ther; 2009 Mar; 9(3):303-16. PubMed ID: 19275509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Screening for adenocarcinoma in Barrett's esophagus: yes or no, when and how?].
    Sostres C; Lacarta P; Lanas A
    Gastroenterol Hepatol; 2013 Oct; 36(8):520-6. PubMed ID: 23453559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience.
    Chennat J; Konda VJ; Ross AS; de Tejada AH; Noffsinger A; Hart J; Lin S; Ferguson MK; Posner MC; Waxman I
    Am J Gastroenterol; 2009 Nov; 104(11):2684-92. PubMed ID: 19690526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A guide for surveillance of patients with Barrett's esophagus.
    Provenzale D; Kemp JA; Arora S; Wong JB
    Am J Gastroenterol; 1994 May; 89(5):670-80. PubMed ID: 8172136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Barrett's esophagus surveillance on esophageal preservation, tumor stage, and survival with esophageal adenocarcinoma.
    Grant KS; DeMeester SR; Kreger V; Oh D; Hagen JA; Chandrasoma P; DeMeester TR
    J Thorac Cardiovasc Surg; 2013 Jul; 146(1):31-7. PubMed ID: 23312980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probe-based confocal laser endomicroscopy compared with standard four-quadrant biopsy for evaluation of neoplasia in Barrett's esophagus.
    Bajbouj M; Vieth M; Rösch T; Miehlke S; Becker V; Anders M; Pohl H; Madisch A; Schuster T; Schmid RM; Meining A
    Endoscopy; 2010 Jun; 42(6):435-40. PubMed ID: 20506064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus.
    Levine DS; Haggitt RC; Blount PL; Rabinovitch PS; Rusch VW; Reid BJ
    Gastroenterology; 1993 Jul; 105(1):40-50. PubMed ID: 8514061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimizing endoscopic biopsy detection of early cancers in Barrett's high-grade dysplasia.
    Reid BJ; Blount PL; Feng Z; Levine DS
    Am J Gastroenterol; 2000 Nov; 95(11):3089-96. PubMed ID: 11095322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.